Concepedia

Bryant M. Foreman

BM

Statistics

Publications

12

Citations

1K

H-Index

11

Active since

2017

Affiliations

National Institute of Allergy and Infectious Diseases(Current)

National Institutes of Health

Moderna Therapeutics (United States)

Washington University in St. Louis

Takeda (United States)

Bryant M. Foreman is an author at National Institute of Allergy and Infectious Diseases specializing in infectious diseases, vaccination, and vaccinology.

Publications per year

2017–2023

12

Publications

12

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

Martin R. Gaudinski, Katherine V. Houser, Kaitlyn M. Morabito et al. · The Lancet · 2017 · 304 citations · Full text

, , +17

Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease

Justin M. Richner, Brett W. Jagger, Chao Shan et al. · Cell · 2017 · 267 citations · Full text

, , +10

An mRNA Vaccine Protects Mice against Multiple Tick-Transmitted Flavivirus Infections

Laura A. VanBlargan, Sunny Himansu, Bryant M. Foreman et al. · Cell Reports · 2018 · 127 citations · Full text

, , +17

Development of a potent Zika virus vaccine using self-amplifying messenger RNA

Kate Luisi, Kaitlyn M. Morabito, Katherine E. Burgomaster et al. · Science Advances · 2020 · 82 citations · Full text

, , +17

An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection

Brooke Bollman, Naveen Nunna, Kapil Bahl et al. · npj Vaccines · 2023 · 58 citations · Full text

, , +17

1–5 of 12